Lv11
30 积分 2025-07-02 加入
Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway
41分钟前
已完结
TRIM21‐Mediated K11‐Linked Ubiquitination of ID1 Suppresses Tumorigenesis and Promotes Cuproptosis in Esophageal Squamous Cell Carcinoma
4个月前
已完结
TRIM21‐Mediated K11‐Linked Ubiquitination of ID1 Suppresses Tumorigenesis and Promotes Cuproptosis in Esophageal Squamous Cell Carcinoma
4个月前
已完结
A Polymeric Hydrogel to Eliminate Programmed Death-Ligand 1 for Enhanced Tumor Radio-Immunotherapy
4个月前
已完结
Tumor Metabolism Aiming Cu2–xS Nanoagents Mediate Photothermal-Derived Cuproptosis and Immune Activation
4个月前
已完结
Tumor Microenvironment Reprogrammed Bimetallic Hybrid Nanostimulator for Triggering Radio‐Cuproptosis‐Immunotherapy
4个月前
已完结
Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond
4个月前
已完结
Nanomaterial‐Triggered Ferroptosis and Cuproptosis in Cancer Therapy
4个月前
已完结
RSPO3 regulates the radioresistance of Non-Small cell lung cancer cells via NLRP3 Inflammasome-Mediated pyroptosis
4个月前
已完结
Cuproptosis-Inducing Functional Nanocomposites for Enhanced and Synergistic Cancer Radiotherapy
4个月前
已完结
皖公网安备34019202002308
